J&J booster slashes Omicron hospitalizations, study shows
Reuters, 31 Dec 2021
A booster dose of Johnson & Johnson's single-dose COVID-19 vaccine was 84% effective at preventing hospitalization in South African healthcare workers who became infected as the Omicron variant spread, researchers said on Thursday.
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en